{
  "name": "CPAM0002",
  "description": "Vacuolar myopathy with autophagy, X-linked vacuolar myopathy with autophagy",
  "nominated_by": "Dr. Person One",
  "latest_status": "Approved",
  "created_date": "2020-11-09",
  "last_modified_date": "2021-03-16",
  "genomic_units": [
    {
      "gene": "VMA21",
      "transcripts": [
        {
          "transcript": "NM_001017980.3"
        }
      ],
      "variants": [
        {
          "hgvs_variant": "NM_001017980.3:c.164G>T",
          "c_dot": "c.164G>T",
          "p_dot": "p.Gly55Val",
          "build": "hg19",
          "case": [
            {
              "field": "Evidence",
              "value": [
                "PVS1",
                "PM2"
              ]
            },
            {
              "field": "Other Datasource",
              "value": [
                "PVS1",
                "PM2"
              ]
            },
            {
              "field": "Interpretation",
              "value": [
                "Likely Pathogenic"
              ]
            }
          ]
        }
      ]
    },
    {
      "gene": "DMD",
      "transcripts": [],
      "variants": [
        {
          "hgvs_variant": "",
          "c_dot": "",
          "p_dot": "",
          "build": "",
          "case": [
            {
              "field": "Interpretation",
              "value": [
                "Variant of Uncertain Significance"
              ]
            }
          ]
        }
      ]
    }
  ],
  "sections": [
    {
      "header": "Brief",
      "content": [
        {
          "field": "Nominated",
          "value": []
        },
        {
          "field": "Reason",
          "value": []
        },
        {
          "field": "Desired Outcomes",
          "value": [
            "Review of ACMG classification",
            "Functional impact study (in silico/animal/cell modeling)",
            "Therapeutic predictions (in silico predictions)"
          ]
        }
      ]
    },
    {
      "header": "Medical Summary",
      "content": [
        {
          "field": "Clinical Diagnosis",
          "value": [
            "Vacuolor myopathy with autophagy, X-linked vacuolor myopathy with autophagy"
          ]
        },
        {
          "field": "Affected Individuals Identified",
          "value": [
            "1 patient, carrier mother"
          ]
        },
        {
          "field": "Pedigree",
          "value": [
            "Maternal grandfather with myopathy.",
            "Mother has muscle signal changes on MRI",
            "Thus presumed to be an X-linked myopathy"
          ]
        }
      ]
    },
    {
      "header": "Pedigree",
      "content": []
    },
    {
      "header": "Case Information",
      "content": [
        {
          "field": "Systems",
          "value": [
            "Musculoskeletal and orthopedics"
          ]
        },
        {
          "field": "HPO Terms",
          "value": [
            "HP:0003198; HP:0003797; HP:0003325; HP:0008997; HP:0008994; HP:0001288; HP:0009060; HP:0004303; HP:0012103; HP:0003736"
          ]
        },
        {
          "field": "Additional Details",
          "value": [
            "8 yo male at time of testing. Ambulatory. Myopathy starting from 2 years of age with falls, elevated CK, and myopathic muscle biopsy. Clinical course is slowly progressive.",
            "Exam showed proximal limb girdle pattern of weakness. Proximal upper and lower extremity weakness. Myopathy Congenital myopathy. Diminished muscle bulk / eps. scapular, Lordotic gait.",
            "Muscle biopsy (2014) showed fiber size variability with prominent perimysial fibrous tissue; scattered myofibers with vacuoles staining dark blue with trichome and positive PAS staining; normal enzyme activity for phosphorylase, myoadenylase and phosphofructokinase.",
            "Electron microscopy (2014) showed membrane bound vacuoles which contain glycogen and degenerated mitochondria; some of these vacuoles contain secondary lysosomes.",
            "CK level 1121U/L."
          ]
        },
        {
          "field": "Experimental Design",
          "value": []
        },
        {
          "field": "Prior Testing",
          "value": [
            "DMD, LAMP2, myofibrillar myopathy panel performed testing for BAG3, crystalline B, desmin, DNAJB6, FLH1, LDB3, and myotilin. Non diagnostic.",
            "DMD testing revealed a hemizygous variant of unknown significance in the DMD gene.",
            "Fulgent Diagnostics identified a hemizygous VUS in the VMA21(XMEA); c.164G>T (p.Gly55Val). His mother also carried this variant."
          ]
        }
      ]
    }
  ],
  "supporting_evidence_files": [
    {
      "filename": "test.txt", 
      "attachment_id": "633afb87fb250a6ea1569555", 
      "comments": "hello world"
    }
  ]
}